Laddar...
Evaluation of inhibitor antibody in hemophiliaA population
Background: Inhibitor antibody to exogenous Factor VIII (FVIII) is a major complication of hemophilia treatment. This study was conducted to determine the prevalence of inhibitor antibody directed against FVIII. Methods: From May 2010 to May 2011, 52 patients with severe hemophilia A admitted in Ami...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Babol University of Medical Sciences
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3755836/ https://ncbi.nlm.nih.gov/pubmed/24009969 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|